Answers are grounded in this paper and cite their sources.
Lu-NM600 targeted radionuclide therapy has potential for TNBC and merits further exploration in a clinical setting.
No takes yet. Share an insight, caveat, or question.
Hernandez et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: